Boston Partners’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474M Buy
1,777,664
+139,473
+9% +$38.6M 0.5% 70
2025
Q4
$451M Buy
1,638,191
+1,243,056
+315% +$348M 0.47% 75
2025
Q3
$114M Sell
395,135
-13,068
-3% -$3.87M 0.12% 208
2025
Q2
$135M Sell
408,203
-6,001
-1% -$1.93M 0.15% 197
2025
Q1
$136M Sell
414,204
-229,103
-36% -$69M 0.16% 181
2024
Q4
$178M Sell
643,307
-1,080,728
-63% -$345M 0.22% 159
2024
Q3
$596M Buy
1,724,035
+104,660
+6% +$36M 0.7% 37
2024
Q2
$536M Sell
1,619,375
-1,659
-0.1% -$572K 0.67% 42
2024
Q1
$588M Sell
1,621,034
-20,603
-1% -$6.78M 0.7% 32
2023
Q4
$492M Sell
1,641,637
-357,026
-18% -$104M 0.65% 42
2023
Q3
$573M Sell
1,998,663
-732,732
-27% -$209M 0.79% 26
2023
Q2
$766M Sell
2,731,395
-129,238
-5% -$33.7M 1.03% 15
2023
Q1
$731M Sell
2,860,633
-353,981
-11% -$103M 1% 17
2022
Q4
$1.06B Sell
3,214,614
-159,330
-5% -$50.4M 1.44% 4
2022
Q3
$941M Sell
3,373,944
-319,705
-9% -$90M 1.38% 5
2022
Q2
$974M Buy
3,693,649
+45,388
+1% +$11.7M 1.36% 6
2022
Q1
$875M Sell
3,648,261
-230,853
-6% -$54M 1.06% 14
2021
Q4
$891M Sell
3,879,114
-60,544
-2% -$12.9M 1.07% 10
2021
Q3
$789M Buy
3,939,658
+832,024
+27% +$181M 1% 14
2021
Q2
$737M Sell
3,107,634
-85,517
-3% -$21.4M 0.94% 16
2021
Q1
$772M Sell
3,193,151
-513,004
-14% -$114M 1.04% 13
2020
Q4
$772M Sell
3,706,155
-147,929
-4% -$29M 1.2% 8
2020
Q3
$653M Sell
3,854,084
-177,769
-4% -$31.3M 1.19% 8
2020
Q2
$757M Sell
4,031,853
-500,647
-11% -$95M 1.39% 7
2020
Q1
$803M Sell
4,532,500
-344,941
-7% -$66.9M 1.59% 6
2019
Q4
$997M Sell
4,877,441
-235,379
-5% -$43.2M 1.32% 7
2019
Q3
$777M Sell
5,112,820
-22,818
-0.4% -$3.71M 1.05% 18
2019
Q2
$810M Buy
5,135,638
+239,730
+5% +$37.6M 1.06% 15
2019
Q1
$787M Buy
4,895,908
+1,261,911
+35% +$230M 1.04% 17
2018
Q4
$690M Buy
3,633,997
+289,480
+9% +$60.4M 0.99% 22
2018
Q3
$696M Buy
3,344,517
+440,296
+15% +$81.6M 0.81% 29
2018
Q2
$494M Buy
2,904,221
+17,675
+0.6% +$3.06M 0.59% 46
2018
Q1
$484M Buy
2,886,546
+186,018
+7% +$36.2M 0.58% 48
2017
Q4
$548M Sell
2,700,528
-60,524
-2% -$12M 0.65% 40
2017
Q3
$516M Sell
2,761,052
-106,022
-4% -$18.9M 0.64% 39
2017
Q2
$480M Sell
2,867,074
-737,619
-20% -$119M 0.61% 44
2017
Q1
$528M Buy
3,604,693
+108,880
+3% +$16M 0.67% 39
2016
Q4
$466M Sell
3,495,813
-27,301
-0.8% -$3.57M 0.61% 44
2016
Q3
$459M Sell
3,523,114
-186,577
-5% -$24.4M 0.64% 45
2016
Q2
$475M Buy
3,709,691
+275,913
+8% +$36.4M 0.69% 38
2016
Q1
$471M Buy
3,433,778
+108,814
+3% +$14.9M 0.69% 35
2015
Q4
$487M Buy
3,324,964
+1,285,904
+63% +$177M 0.7% 37
2015
Q3
$275M Buy
2,039,060
+240,217
+13% +$34.9M 0.42% 69
2015
Q2
$291M Buy
1,798,843
+1,660,226
+1,198% +$229M 0.42% 74
2015
Q1
$17.9M Buy
+138,617
New +$16.1M 0.03% 315
2014
Q3
Sell
-1,443,997
Closed -$133M 723
2014
Q2
$133M Sell
1,443,997
-1,614,069
-53% -$138M 0.22% 122
2014
Q1
$256M Sell
3,058,066
-1,211,238
-28% -$99.7M 0.47% 64
2013
Q4
$373M Sell
4,269,304
-649,993
-13% -$53.2M 0.77% 31
2013
Q3
$378M Buy
4,919,297
+250,452
+5% +$19.6M 0.91% 23
2013
Q2
$338M Buy
+4,668,845
New +$315M 0.93% 23

Other funds holding CI

Boston Partners's CI Position: Q1 2026 in Review

Boston Partners increased its Cigna (CI) stake by 8.5% in Q1 2026, buying an estimated $38.6M and bringing the position to 1,777,664 shares worth $474M. The position accounts for 0.5% of the portfolio, ranked #70.

Boston Partners first reported a position in CI in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.06B in Q4 2022. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Boston Partners held 1,777,664 shares of Cigna worth $474M as of Q1 2026.
  • Boston Partners bought 139,473 Cigna shares in Q1 2026, an estimated $38.6M.
  • Cigna made up 0.5% of Boston Partners's portfolio in Q1 2026, its #70 holding.
  • Boston Partners first reported a position in Cigna in Q2 2013 and has held it in 50 quarters since.
  • Boston Partners's Cigna position peaked at $1.06B in Q4 2022.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.